← Open Payments lookup

LEIGH CALCOTE: Open Payments

NPI 1508598376 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,862 in 140 payments from 17 companies in 2025. Trend: 2023 $1,652 · 2024 $8,232 · 2025 $4,862

Food & beverage: $2,862Speaker / faculty: $2,000
CompanyPaymentsAmount
ABBVIE INC.24$2,533
Axsome Therapeutics, Inc.24$516
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$488
Vanda Pharmaceuticals Inc.14$225
Teva Pharmaceuticals USA, Inc.6$164
Supernus Pharmaceuticals, Inc.7$149
Takeda Pharmaceuticals U.S.A., Inc.8$143
Otsuka America Pharmaceutical, Inc.4$114
Collegium Pharmaceutical, Inc.6$114
E.R. Squibb & Sons, L.L.C.5$106

Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, REXULTI, AUSTEDO XR, Qelbree, TRINTELLIX.

Industry payments across MS — which companies pay providers there.